Email a Friend
Print ArticleHealthy Aging Health Center
Aging Better: Resources
WebMD Men’s Health Guide
This link will take you to WebMD’s comprehensive guide to men’s health.
Related Guide: WebMD Men’s Health Guide
WebMD Women’s Health Guide
This link takes you to WebMD’s Women’s Health Guide.
Related Guide: WebMD Women’s Health Guide
WebMD Active Aging Support Group
People are talking about what aging means in the 21st century -- share your views on WebMD’s Active Aging Support Group message board.
Message Board: WebMD Active Aging Support Group
WebMD Message Board: Medicare and You
This WebMD message board is all about Medicare. Join the conversation.
Message Board: Medicare and You
WebMD’s Caregiving Message Board
Are you a caregiver? You’re welcome to participate in WebMD’s caregiving message board.
WebMD’s Caregiving Message Board
National Institute on Aging
The National Institute on Aging (NIA) is part of the National Institutes of Health. This link takes you to NIA’s web site.
Related Web Site: National Institute on Aging
AARP
Formerly called the American Association of Retired People, AARP is for people age 50 and older. This link takes you to its web site.
More Medicare Resources
Get a list of 10 organizations that have information on Medicare. This link takes you to an outside site.
Related Web Site: More Medicare Resources
Medicare Web Site
This link takes you to the U.S. government’s Medicare web site.
Related Web Site: Medicare Web Site
Medicare Contacts
This link takes you to the Medicare web site’s “Helpful Contacts” page.
Related Web Site: Medicare Contacts
WebMD Medical Reference
Healthy Aging Guide
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Please see UROXATRAL full prescribing information.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.
Do You Need an Annual Check Up?
Are annual checkups worth your time and money? Not everyone agrees.
Do Your Hands Reveal Your Age?
